Pavlo Osos


The subject of this article is the state of investment attractiveness of the pharma-ceutical industry of Ukraine in connection with the spread of coronavirus disease COVID-19. Methodology. The study mainly used systemic and logical ap-proaches. At the same time, the following scientific methods were used in the re-search process: 1) analysis – the risks and benefits of investing in the pharmaceu-tical industry in Ukraine are studied, in particular, the main factors that may af-fect its further development are identified; 2) deduction – the general state of op-eration of the pharmaceutical industry and important details that form a general picture of the industry are indicated; 3) induction – considerable attention has been paid to some important steps necessary for the further development of the pharmaceutical industry; 4) generalization – common features of the processes occurring at the national and supranational level in the functioning of the phar-maceutical industry have been established; 5) others. The aim of this article is to identify new opportunities, prospects and risks for investment in the pharmaceu-tical industry of Ukraine in connection with the spread of coronavirus disease COVID-19 (hereinafter COVID-19). The results of the study demonstrate the significant potential of the pharmaceutical industry in Ukraine for its further transformation: high employment in the industry, a large number of production facilities, compliance with international standards, etc. Conclusion. The pharma-ceutical industry of Ukraine is one of the most profitable sectors of the national economy and has a leading position on the index of capital investment. Despite the economic crisis, the industry's focus on innovation is driving growth, particu-larly in the pharmaceutical market. 48% of pharmaceutical manufacturers pay special attention to the study of new technologies and equipment. For further de-velopment of the domestic pharmaceutical industry, Ukraine needs an effective strategy for implementing the stages of vaccine production on its territory due to the emergence of new diseases. Production of such vaccines will help support Ukraine's participation in competition in the promising segment of the global pharmaceutical market. In order to attract investment in the development of this area, the Ukrainian government needs to ensure the effective functioning of public authorities and, in particular, to ensure the predictability of the economic and po-litical situation. Given the positive experience of foreign countries (USA, India and Kazakhstan) in cooperation in the format of public-private partnerships (hereinafter – PPP), the introduction and further use of this mechanism of coop-eration in the pharmaceutical industry of Ukraine will have a positive impact on its investment attractiveness. Effective actions of the government of Ukraine, aimed at improving the welfare of citizens will serve as a guarantee of preventing the growth of counterfeit pharmaceutical products on the domestic market.

How to Cite

Article views: 339 | PDF Downloads: 185



pharmaceutical industry, public-private partnership, investment attractiveness, investment risks, national economy, СOVID-19


Krupiak, I. Y., & Krupiak, L. B. (2018). Finansovi aspekty rozvytku farmatsevtychnoi haluzi derzhavy [Financial aspects of development pharmaceutical industry of the state]. Economy and Society, vol. 19, no. 160, pp. 1072–1078. Available at: (accessed December 2, 2021).

Speights, K. (2021). Investing in Pharmaceutical stocks. The Motley Fool. Available at: (accessed December 2, 2021).

PwC Ukraine (2021). Farmatsevtychna haluz [Pharmaceutical branch]. PwC Ukraine. Available at: (accessed November 29, 2021).

Fred D. Ledley, MD., Sarah Shonka McCoy, PhD., Gregory Vaughan, PhD., Ekaterina Galkina Cleary, PhD (2020). Profitability of Large Pharmaceuti-cal Companies Compared with other Large Public Companies. JAMA Network. Available at: (ac-cessed December 1, 2021).

Borushchak, I. (2017). Suchasni tendentsii rozvytku farmatsevtychnoho rynku Ukrainy v umovakh hlobalnykh strukturnykh zrushen [Current trends in the development of the pharmaceutical market of Ukraine in the context of global structural changes]. Proceeding of the Napriamy stiikoho zrostannia u svitovii ekonomitsi (Ukraine, Ternopil, April 20–21,2017) (eds. Hrodskyi S. V., Zvarych I. Ya., Karas O. S, Ternopil: Napriamy stiikoho zrostznnia u svitovii ekonomitsi, pp. 141–144. Available at: (accessed December 2, 2021).

European Federation of Pharmaceutical Industries and Associations (2021) The pharmaceutical Industry in Figures. European Federation of Pharmaceutical Industries and Associations, p. 9. Available at: (accessed December 2, 2021).

Ukrinform (2021). Yevrosoiuz daie €30 milioniv kredytu dlia rozrobky COVID-vaktsyny [The European Union is providing a € 30 million loan to de-velop a COVID vaccine]. Ukrinform. Available at: (accessed December 2, 2021).

Vitiuk, A. V., & Trachenko, K. R. (2018). Superechlyvi tendentsii Rozvytku farmatsevtychnoi promyslovosti Ukrainy [Supplementary trends in Development of the Pharmaceutical Industry of Ukraine]. Bulletin of Vinnytsia Politechnic Institute no. 6, pp. 35–43. Available at: (accessed Decem-ber 2, 2021).

Beha, V. (2020). MOZ khoche vidnovyty vyrobnytstvo vaktsyn v Ukraini. Ale tse ne nadto realistychno [The Ministry of Health wants to resume vaccine production in Ukraine. But this is not very realistic]. Hromadske. Available at: (accessed December 2, 2021).

Mind UA (2021). Kryza yak mozhlyvist zrostannia farmrynku [Crisis as an opportunity to grow the pharmaceutical market]. Mind UA. Available at: (accessed December 2, 2021).

UFUTURE (2020). Ukrainska farma otrymuie naibilshe kapitalnykh inves-tytsii druhyi rik pospil [Ukrainian pharmaceutical branch receives most capital investment for the second year in a row]. UFUTURE. Available at: (accessed December 4, 2021).

Ukrainian government's investment promotion agency UkraineInvest (2020) Farmatsevtyka [Pharmaceutics]. Ukrainian government's investment pro-motion agency UkraineInvest. Available at: (accessed December 2, 2021).

Vinnytsia Regional Employment Center (2021) Khto taki farmatsevty? [Who are pharmacists?]. Vinnytsia Regional Employment Center. Available at: (accessed December 2, 2021).

Radutskyi, M. (2020). Zakon "Pro likarski zasoby": shcho i chomu zmini-uiemo [Law "On Medicines": what and why we change]. Ukrainian Truth. Avail-able at: (accessed De-cember 2, 2021).

Litvinova, O. V., & Posylkina, O. V. (2019). Aktualnist vprovadzhennia mekhanizmiv derzhavno-pryvatnoho partnerstva pry realizatsii innovatsiinykh proektiv zi stvorennia likarskykh zasobiv, pryznachenykh dlia likuvannia sotsi-alno zahrozlyvykh zakhvoriuvan [Public-private partnership in the implementa-tion of innovative projects associated with pharmaceutical developments for the treatment of socially significant diseases]. Pharmaceutical review, no. 1, pp. 79–87. Available at: (accessed December 2, 2021).

Posylkina, O. V. (2002). Investytsiina pryvablyvist obiekta [Investment at-tractiveness of the object]. Pharmaceutical encyclopedia. Available at: (accessed December 2, 2021).

Kovinko, O. M., Stakhova, A. I., & Vovk, A. P. (2017). Farmatsevtychnyi rynok Ukrainy yak rushiinyi vazhil rozvytku ekonomiky [Pharmaceutical market of Ukraine as the driving level of economic development]. Scientific Bulletin of Uzhhorod National University vol. 11, pp. 56–59. Available at: (accessed December 5, 2021)

Kulytskyi, S. (2019). Farmatsevtychna haluz i farmatsevtychnyi rynok v Ukraini: stan i problemy rozvytku [Pharmaceutical branch and pharmaceutical market in Ukraine: state and problems of development]. Social Communications Research Center. Available at: (accessed December 2, 2021).